Company Profile for Quintiles
September 26 2014 - 12:14PM
Business Wire
Quintiles, a Fortune 500 company, is the world’s largest
provider of biopharmaceutical development and commercial
outsourcing services. With a network of more than 30,000 employees
conducting business in approximately 100 countries, we helped
develop or commercialize all of 2013’s top-100 best-selling drugs
on the market.
Quintiles applies the breadth and depth of our service offerings
along with extensive therapeutic, scientific and analytics
expertise to help our customers navigate an increasingly complex
healthcare environment as they seek to improve efficiency and
effectiveness in the delivery of better healthcare outcomes.
At Quintiles, we improve customers’ probability of success by
connecting insights with superior delivery.
This is our way of working together differently to shape ideas,
execute effectively and share success. Today, Quintiles brings a
fully integrated approach to build biopharma and life sciences
solutions -- from pipeline through portfolio to population health.
The goals customers set define the work we do and the standards we
work to achieve.
PRODUCT DEVELOPMENT
Our Product Development group enables biopharmaceutical
companies, including medical device companies and diagnostics
companies, to outsource clinical development, from first-in-human
studies to post-launch monitoring.
Our comprehensive services provide scientific and analytical
expertise, global access, best in class technology, and local and
global regulatory expertise at each stage of development to help
our customers improve product development efficiency and
effectiveness. Product Development is comprised Clinical solutions
and services include project management and clinical monitoring
functions for conducting multi-site trials (generally Phase II-IV),
collectively known as “core clinical.”
Our global laboratories, data management, biostatistics, safety
and pharmacovigilance, early clinical development (generally Phase
I), and strategic planning and design services enable us to provide
end-to-end solutions to our customers. Consulting provides strategy
and management consulting services based on life science expertise
and advanced analytics, as well as regulatory and compliance
consulting services.
INTEGRATED HEALTHCARE SERVICES (IHS)
Quintiles’ Integrated Healthcare Services (IHS) address the
outsourced commercial needs of biopharmaceutical customers as well
as the needs of the broader healthcare sector for value-based
analyses, research studies and evidence-based medicine.
Service offerings include commercial services such as sales
representatives, strategy, market access, marketing communications
and other areas related to commercialization.
Outcomes research including drug therapy analysis, real-world
research and evidence-based medicine, including research studies to
prove a drug’s value are also part of our IHS offering along with
comparative and cost-effectiveness research, clinical management
analytics, decision support services, medication adherence and
health outcome optimization services, and web-based systems for
measuring quality improvement.
Company:
Quintiles
Headquarters Address:
4820 Emperor Boulevard Durham, NC 27703
Main Telephone:
919.998.2000
Website:
www.Quintiles.com
Ticker/ISIN:
Q(NYSE)/US74876Y1010
Type of Organization:
Public
Industry:
Pharmaceutical
Key Executives:
CEO: Tom Pike
CFO: Kevin Gordon
Public Relations
Contact:
Phil Bridges
Phone:
919.998.1653
Email:
phil.bridges@quintiles.com
Public Relations
Contact:
Mari Mansfield
Phone:
919.998.2639
Email:
mari.mansfield@quintiles.com
Investor Relations
Contact:
Karl Deonanan
Phone:
919.998.2789
Email:
InvestorRelations@quintiles.com
Qimonda AG Ads (NYSE:QI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Qimonda AG Ads (NYSE:QI)
Historical Stock Chart
From Oct 2023 to Oct 2024